Stefanie Flückiger

Stefanie Flückiger, co-founder and CEO of Tolremo Therapeutics, leads a dynamic biotech company focused on combating non-genetic drug resistance in cancer treatment. In this conversation, she shares her journey from academia to entrepreneurship, emphasizing the importance of diversity in driving innovation. Stefanie delves into the science behind cancer cell resistance, discussing how tumors adapt to treatments. She also reflects on her personal aspirations and the valuable lessons learned along the way, blending scientific rigor with heartfelt insights.